Molecular Quest Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-07-2024
- Paid Up Capital ₹ 0.26 M
as on 16-07-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.90 M
as on 16-07-2024
- Revenue -60.12%
(FY 2023)
- Profit -149.11%
(FY 2023)
- Ebitda -138.73%
(FY 2023)
- Net Worth -27.29%
(FY 2023)
- Total Assets -16.83%
(FY 2023)
About Molecular Quest Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.26 M.
The company has closed loans amounting to ₹0.90 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sunil Goyal and Amit Verma serve as directors at the Company.
- CIN/LLPIN
U85100HR2012PTC047641
- Company No.
047641
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Molecular Quest Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Verma  | Director | 23-Feb-2021 | Current |
| Sunil Goyal | Director | 09-Nov-2012 | Current |
Financial Performance of Molecular Quest Healthcare.
Molecular Quest Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 60.12% decrease. The company also saw a substantial fall in profitability, with a 149.11% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Molecular Quest Healthcare?
In 2022, Molecular Quest Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maa Devi Shakumbhari Solutions Private LimitedActive 11 years 16 daysSunil Goyal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Mar 2019 | ₹0.90 M | Satisfied |
How Many Employees Work at Molecular Quest Healthcare?
Molecular Quest Healthcare has a workforce of 56 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Molecular Quest Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecular Quest Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
